Alarin-mediated pleiotropic NPY release from hypothalamic explants directly enters into the adipose tissue by activating NPY-Y2 receptors to influence GLUT4 mRNA expression in adipocytes of subjects as well as to accelerate glucose intake that stimulates appetite and obesity (5, 47). Here, NPY is linked to obesity disorder.